Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Beyer

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
Zeitschrift Fur Rheumatologie|March 25, 2014
[Trends in rehabilitation of patients with rheumatic diseases in Germany]W Mau, W Beyer, I Ehlebracht-König, et al.
The EMBO Journal|June 16, 1999
Activation of the erythropoietin receptor by the gp55-P viral envelope protein is determined by a single amino acid in its transmembrane domainS N Constantinescu, X Liu, W Beyer, et al.
Zeitschrift Fur Kardiologie|September 1, 1991
Plasma hormones in patients with chronic heart failure before and early after orthotopic heart transplantationC H Spes, C E Angermann, R Gerzer, et al.
Pneumologie (Stuttgart, Germany)|March 1, 1990
[Photodynamic therapy of bronchial cancer]K Häussinger, R M Huber, M Krug, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2011
Humanized theta-defensins (retrocyclins) enhance macrophage performance and protect mice from experimental anthrax infectionsS Welkos, C K Cote, U Hahn, et al.
Diabetes Care|February 28, 2009
Diabetes in non-Hispanic white youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth StudyRonny A Bell, Elizabeth J Mayer-Davis, Jennifer W Beyer, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 6, 2013
Anthrax among heroin users in Europe possibly caused by same Bacillus anthracis strain since 2000R Grunow, S R Klee, W Beyer, et al.
Cancer Treatment Reports|January 1, 1981
Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumorsE A Neuwelt, S A Hill, E P Frenkel, et al.
Transactions of the American Neurological Association|January 1, 1979
Osmotic blood-brain barrier disruption: a new means of increasing chemotherapeutic agent deliveryE A Neuwelt, E P Frenkel, J T Diehl, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Zeitschrift Fur Rheumatologie|March 25, 2014
[Trends in rehabilitation of patients with rheumatic diseases in Germany]W Mau, W Beyer, I Ehlebracht-König, et al.
The EMBO Journal|June 16, 1999
Activation of the erythropoietin receptor by the gp55-P viral envelope protein is determined by a single amino acid in its transmembrane domainS N Constantinescu, X Liu, W Beyer, et al.
Zeitschrift Fur Kardiologie|September 1, 1991
Plasma hormones in patients with chronic heart failure before and early after orthotopic heart transplantationC H Spes, C E Angermann, R Gerzer, et al.
Pneumologie (Stuttgart, Germany)|March 1, 1990
[Photodynamic therapy of bronchial cancer]K Häussinger, R M Huber, M Krug, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2011
Humanized theta-defensins (retrocyclins) enhance macrophage performance and protect mice from experimental anthrax infectionsS Welkos, C K Cote, U Hahn, et al.
Diabetes Care|February 28, 2009
Diabetes in non-Hispanic white youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth StudyRonny A Bell, Elizabeth J Mayer-Davis, Jennifer W Beyer, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 6, 2013
Anthrax among heroin users in Europe possibly caused by same Bacillus anthracis strain since 2000R Grunow, S R Klee, W Beyer, et al.
Cancer Treatment Reports|January 1, 1981
Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumorsE A Neuwelt, S A Hill, E P Frenkel, et al.
Transactions of the American Neurological Association|January 1, 1979
Osmotic blood-brain barrier disruption: a new means of increasing chemotherapeutic agent deliveryE A Neuwelt, E P Frenkel, J T Diehl, et al.
Pageof 12